Use access key #2 to skip to page content.
$31.77 0.44 (1.40%)
7/23/2008 4:00 PM

Merck & Co., Inc. (MRK)

CAPS Rating:
****

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

View All Commentary (MRK)

Recs

0

Avatar Money2themax (75.06) Submitted: 5/07/08 12:28 AM : Underperform Start Price: $38.47 MRK Score: 7.72

Merck has been hammered. It will remain down for the count until a new drug can gain FDA approval. The only thing that can bring this company back early is if Merck purchases a biotech with a drug in Stage IIi or III Trials that, again, makes it past FDA scrutiny.

Report this Post Replies: 0 | Reply

Featured Broker Partners